Cystinosis

Last updated: September 12, 2024

Cystinosis

HMBP Exam

HMBP Exam

Introduction to pharmacology
Light microscopy and staining methods
Cytoskeleton and intracellular motility
Pharmacodynamics: Agonist, partial agonist and antagonist
Cellular structure and function
Primary ciliary dyskinesia
Nuclear structure
DNA structure
Transcription of DNA
Translation of mRNA
Epigenetics
DNA damage and repair
DNA mutations
Rett syndrome
Amino acids and protein folding
Protein structure and synthesis
Osmosis
Myasthenia gravis
Cell membrane
Human development days 1-4
Human development days 4-7
Human development week 2
Selective permeability of the cell membrane
Prions (Spongiform encephalopathy)
Ehlers-Danlos syndrome
Osteogenesis imperfecta
Cystic fibrosis
Ectoderm
Mesoderm
Endoderm
Diabetes mellitus
Beta-thalassemia
Inheritance patterns
Independent assortment of genes and linkage
Mitosis and meiosis
Karyotyping
Glycolysis
Gluconeogenesis
Essential fructosuria
Hereditary fructose intolerance
Amino acid metabolism
Arsenic poisoning
Patau syndrome (Trisomy 13)
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Turner syndrome
Klinefelter syndrome
Angelman syndrome
Prader-Willi syndrome
Marfan syndrome
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pentose phosphate pathway
Glycogen metabolism
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type V
Glycogen storage disease type IV
Glycogen storage disease type III
Ketone body metabolism
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Cri du chat syndrome
Williams syndrome
Fatty acid synthesis
Fatty acid oxidation
Nucleotide metabolism
Cystinosis
Antimetabolites for cancer treatment
Severe combined immunodeficiency
Lesch-Nyhan syndrome
Megaloblastic anemia
Hartnup disease
Cystinuria (NORD)
Drug administration and dosing regimens
Nitrogen and urea cycle
Cell cycle
Cholesterol metabolism
Fragile X syndrome
Huntington disease
Friedreich ataxia
Polycystic kidney disease
Achondroplasia
Neurofibromatosis
Albinism
Niemann-Pick disease types A and B (NORD)
Tay-Sachs disease (NORD)
Fabry disease (NORD)
Alkaptonuria
Ornithine transcarbamylase deficiency
Homocystinuria
Maple syrup urine disease
Krabbe disease
Gaucher disease (NORD)
Niemann-Pick disease type C
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Phenylketonuria (NORD)
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Wernicke-Korsakoff syndrome
Zellweger spectrum disorders (NORD)
Vitamin C deficiency
Adenosine deaminase deficiency
Xeroderma pigmentosum
Fanconi anemia
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Gel electrophoresis and genetic testing
Fluorescence in situ hybridization
ELISA (Enzyme-linked immunosorbent assay)
Hardy-Weinberg equilibrium
Hemochromatosis
Alpha-thalassemia
Hemophilia
Muscular dystrophy
Mitochondrial myopathy
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions

Transcript

Watch video only

With cystinosis, “cystin-” refers to cystine, an amino acid, and “-osis” implies disease.

So, cystinosis is a rare condition caused by mutations of the CTNS gene that leads to a cystine buildup in the body.

This can cause tissue damage, especially in the kidneys and eyes.

Cystine is an amino acid that comes from our diet.

When food travels through the stomach and intestines, the proteins within, are broken down into tiny fragments, called oligopeptides, or small strings of amino acids.

Turnover of muscle, bone and other parts of the body provide another source of protein that can be broken down into oligopeptides.

Many of these oligopeptides end up in specialized vesicles, called lysosomes, found inside all of our cells.

Here, they are further broken up into amino acids like cystine.

Now, cystine, like any other amino acid has to leave the lysosome, and it does this with the help of a specific protein.

Generally, genes tell our bodies how to make proteins.

So, the CTNS gene encodes for the protein cystinosin, a transporter that is found embedded in the lysosomal membrane.

It’s function is to export cystine out of the lysosome.

Now, in cystinosis, any one of over 100 mutations can affect the CTNS gene, leading to a defective cystine transporter.

Without a working transporter, cystine has no way of leaving the lysosome, so it accumulates, turning into cystine crystals in the process.

Crystals that slowly damage organs like the kidneys and eyes.

In general, humans have two copies of their genes, so both must be damaged for there to be so little cystine transport that cystinosis occurs.

That means that a person with cystinosis must receive a mutated CTNS gene from both the mother and father.

For each such mating, there is a 25% chance that both parents will pass down their own CTNS mutation to the offspring.

Now, depending on the CTNS gene mutation, three types of cystinosis can develop that differ in the age of onset and severity of symptoms.

They are nephropathic, or infantile, late onset, and ocular.

Key Takeaways

Cystinosis is a rare, progressive genetic disorder caused by a mutation in the CTNS gene, which results in the build-up of cystine amino acid in the body. CTNS gene encodes for cystinosin protein, which transports cystine protein out of lysosomes. When it malfunctions, that's when the amino acid accumulates and causes cystinosis. Symptoms include blindness, kidney failure, and muscle weakness.

Sources

  1. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  2. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  3. "Yen & Jaffe's Reproductive Endocrinology" Saunders W.B. (2018)
  4. "Bates' Guide to Physical Examination and History Taking" LWW (2016)
  5. "Robbins Basic Pathology" Elsevier (2017)
  6. "Cystinosis" New England Journal of Medicine (2002)
  7. "The de Toni-Fanconi Syndrome with Cystinosis" A.M.A. Journal of Diseases of Children (1958)
  8. "Lysosomal cystine accumulation promotes mitochondrial depolarization and induction of redox-sensitive genes in human kidney proximal tubular cells" The Journal of Physiology (2016)